{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T05:23:21Z","timestamp":1790573001625,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T00:00:00Z","timestamp":1659052800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004063","name":"Knut and Alice Wallenberg Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2018-05973"],"award-info":[{"award-number":["2018-05973"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ebiom.2022.104214","type":"journal-article","created":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T19:55:53Z","timestamp":1660852553000},"page":"104214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning"],"prefix":"10.1016","volume":"83","author":[{"given":"Cheng","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8643-5846","authenticated-orcid":false,"given":"Mengnan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woonghee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2261-0881","authenticated-orcid":false,"given":"Muhammad","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Klevstig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8301-9959","authenticated-orcid":false,"given":"Xiangyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cemil","family":"Bayram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail","family":"Bolat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem \u00d6zdemir","family":"Tozlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Hac\u0131muftuoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Y\u0131ld\u0131r\u0131m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihad","family":"Sebhaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shazia","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Turkez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"Uhlen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Boren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4254-6090","authenticated-orcid":false,"given":"Adil","family":"Mardinoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ebiom.2022.104214_bib0001","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrgastro.2017.32","article-title":"Lipid droplets and liver disease: from basic biology to clinical implications","volume":"14","author":"Gluchowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104214_bib0002","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cels.2018.01.004","article-title":"Broad views of non-alcoholic fatty liver disease","volume":"6","author":"Mardinoglu","year":"2018","journal-title":"Cell Syst"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104214_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16173104","article-title":"Cardiovascular risk in non-alcoholic fatty liver disease: mechanisms and therapeutic implications","volume":"16","author":"Tana","year":"2019","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104214_bib0004","doi-asserted-by":"crossref","first-page":"938","DOI":"10.15252\/msb.20177703","article-title":"Network analyses identify liver-specific targets for treating liver diseases","volume":"13","author":"Lee","year":"2017","journal-title":"Mol Syst Biol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104214_bib0005","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cels.2017.12.006","article-title":"Integration of multi-omics data from mouse diversity panel highlights mitochondrial dysfunction in non-alcoholic fatty liver disease","volume":"6","author":"Chella Krishnan","year":"2018","journal-title":"Cell Syst"},{"key":"10.1016\/j.ebiom.2022.104214_bib0006","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymben.2019.01.001","article-title":"Pyruvate kinase L\/R is a regulator of lipid metabolism and mitochondrial function","volume":"52","author":"Liu","year":"2019","journal-title":"Metab Eng"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104214_bib0007","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4254\/wjh.v6.i5.274","article-title":"Gender and racial differences in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2014","journal-title":"World J Hepatol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104214_bib0008","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jcmgh.2020.09.004","article-title":"Liver pyruvate kinase promotes NAFLD\/NASH in both mice and humans in a sex-specific manner","volume":"11","author":"Chella Krishnan","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104214_bib0009","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/em.22426","article-title":"Micronucleated erythrocytes in peripheral blood from neonate rats fed by nursing mothers exposed to X-rays","volume":"62","author":"Solorzano-Melendez","year":"2021","journal-title":"Environ Mol Mutagen"},{"issue":"572","key":"10.1016\/j.ebiom.2022.104214_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aba4448","article-title":"Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis","volume":"12","author":"Govaere","year":"2020","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104214_bib0011","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nbt.3519","article-title":"Near-optimal probabilistic RNA-seq quantification","volume":"34","author":"Bray","year":"2016","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"10.1016\/j.ebiom.2022.104214_bib0012","doi-asserted-by":"crossref","first-page":"D754","DOI":"10.1093\/nar\/gkx1098","article-title":"Ensembl 2018","volume":"46","author":"Zerbino","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104214_bib0013","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104214_bib0014","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1093\/nar\/gkt111","article-title":"Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods","volume":"41","author":"Varemo","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104214_bib0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5808\/GI.2016.14.4.173","article-title":"Comparison of two meta-analysis methods: inverse-variance-weighted average and weighted sum of Z-scores","volume":"14","author":"Lee","year":"2016","journal-title":"Genomics Inform"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104214_bib0016","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"D1","key":"10.1016\/j.ebiom.2022.104214_bib0017","doi-asserted-by":"crossref","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.ebiom.2022.104214_bib0018","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1146\/annurev-physiol-021115-105331","article-title":"Pathophysiology and mechanisms of nonalcoholic fatty liver disease","volume":"78","author":"Haas","year":"2016","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.ebiom.2022.104214_bib0019","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/978-3-642-01222-8_11","article-title":"5-Azacytidine\/azacitidine","volume":"184","author":"Muller","year":"2010","journal-title":"Recent Results Cancer Res"},{"issue":"27","key":"10.1016\/j.ebiom.2022.104214_bib0020","doi-asserted-by":"crossref","first-page":"18736","DOI":"10.1074\/jbc.M114.563650","article-title":"The epigenetic drug 5-azacytidine interferes with cholesterol and lipid metabolism","volume":"289","author":"Poirier","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ebiom.2022.104214_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2019.105667","article-title":"Resveratrol alleviates non-alcoholic fatty liver disease through epigenetic modification of the Nrf2 signaling pathway","volume":"119","author":"Hosseini","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ebiom.2022.104214_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/269751","article-title":"AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile in CaCo-2 colon cancer cells","volume":"2012","author":"Cerbone","year":"2012","journal-title":"PPAR Res"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104214_bib0023","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/BJ20060811","article-title":"Insulin induction of glucokinase and fatty acid synthase in hepatocytes: analysis of the roles of sterol-regulatory-element-binding protein-1c and liver X receptor","volume":"399","author":"Hansmannel","year":"2006","journal-title":"Biochem J"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104214_bib0024","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/hep.23280","article-title":"Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications","volume":"51","author":"Fabbrini","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.ebiom.2022.104214_bib0025","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3389\/fendo.2019.00374","article-title":"Liver and steroid hormones-can a touch of p53 make a difference?","volume":"10","author":"Charni-Natan","year":"2019","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104214_bib0026","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1194\/jlr.M700184-JLR200","article-title":"Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes","volume":"49","author":"Han","year":"2008","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104214_bib0027","doi-asserted-by":"crossref","first-page":"G77","DOI":"10.1152\/ajpgi.00301.2011","article-title":"Mechanisms of lysophosphatidylcholine-induced hepatocyte lipoapoptosis","volume":"302","author":"Kakisaka","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.ebiom.2022.104214_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.797923","article-title":"Regression of liver steatosis following phosphatidylcholine administration: a review of molecular and metabolic pathways involved","volume":"13","author":"Osipova","year":"2022","journal-title":"Front Pharmacol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104214_bib0029","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1139\/apnm-2012-0261","article-title":"Nonalcoholic fatty liver disease is associated with lower hepatic and erythrocyte ratios of phosphatidylcholine to phosphatidylethanolamine","volume":"38","author":"Arendt","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104214_bib0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cmet.2011.01.006","article-title":"Crosstalk between components of circadian and metabolic cycles in mammals","volume":"13","author":"Asher","year":"2011","journal-title":"Cell Metab"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104214_bib0031","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41574-018-0122-1","article-title":"Circadian clocks and insulin resistance","volume":"15","author":"Stenvers","year":"2019","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104214_bib0032","doi-asserted-by":"crossref","first-page":"G431","DOI":"10.1152\/ajpgi.00281.2017","article-title":"Genetic deletion of the circadian clock transcription factor BMAL1 and chronic alcohol consumption differentially alter hepatic glycogen in mice","volume":"314","author":"Udoh","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"}],"updated-by":[{"DOI":"10.1016\/j.ebiom.2024.105224","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000}}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422003966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:20:41Z","timestamp":1762456841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422003966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":32,"alternative-id":["S2352396422003966"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104214","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.02.15.480557","asserted-by":"object"}]},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of therapeutic agents targeting PKLR for NAFLD using drug repositioning","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104214"}}